FOLD — AMICUS THERAPEUTICS INC

Ownership history in FOX RUN MANAGEMENT, L.L.C.  ·  10 quarters on record

This page tracks every 13F SEC filing in which FOX RUN MANAGEMENT, L.L.C. reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.17% (2021 Q3)
Avg. % of fund
0.09%
First filed
2018 Q2
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 70,115 +48,666 +226.9% 0.09% $553K $7.88
2025 Q1 REDUCED 21,449 -41,121 -65.7% 0.03% $175K $8.16
2024 Q4 ADDED 62,570 +30,162 +93.1% 0.11% $589K $9.42
2024 Q3 ADDED 32,408 +20,146 +164.3% 0.08% $346K $10.68
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FOLD price (monthly, adj. close)

Other funds also holding FOLD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 10.32% Sand Grove Capital Management LLP 3Y 7Y 7.95% PSquared Asset Management AG 3Y 7Y 6.99% CM Management, LLC 3Y 4.44% Prosight Management, LP 3Y 7Y 3.38% KRYGER CAPITAL Ltd 3Y 3.29% Athos Capital Ltd 3Y 7Y 3.27% Chicago Capital Management, LLC 3Y 7Y 2.92% Bellevue Group AG 3Y 7Y 2.9% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 2.75%
← Back to FOX RUN MANAGEMENT, L.L.C. Holdings